Results 1 to 10 of about 890,674 (306)

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe [PDF]

open access: yesFrontiers in Pharmacology, 2021
Aims: Cardiovascular outcome trials with anti-diabetic drugs suggest that additional cardiovascular benefit can be achieved independent of improving glycaemic control.
Jeroen V. Koomen   +7 more
doaj   +3 more sources

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease [PDF]

open access: yesMediators of Inflammation, 1998
Mesalazine is widely used in the treatment of inflammatory bowel disease. Little is known about the doseresponse relationship and about possible dose related side effects.
C. J. J. Mulder, S. J. Van Den Hazel
doaj   +4 more sources

Multi-output prediction of dose–response curves enables drug repositioning and biomarker discovery [PDF]

open access: yesnpj Precision Oncology
Drug response prediction is hampered by uncertainty in the measures of response and selection of doses. In this study, we propose a probabilistic multi-output model to simultaneously predict all dose–responses and uncover their biomarkers.
Juan-José Giraldo Gutierrez   +6 more
doaj   +3 more sources

Dose optimisation and scarce resource allocation: two sides of the same coin [PDF]

open access: yesBMJ Open, 2022
Objective A deep understanding of the relationship between a scarce drug's dose and clinical response is necessary to appropriately distribute a supply-constrained drug along these lines.Summary of key data The vast majority of drug development and ...
Govind Persad   +3 more
doaj   +3 more sources

Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity [PDF]

open access: yesBMC Medical Research Methodology, 2017
Background It is important to quantify the dose response for a drug in phase 2a clinical trials so the optimal doses can then be selected for subsequent late phase trials. In a phase 2a clinical trial of new lead drug being developed for the treatment of
Feng Liu   +2 more
doaj   +4 more sources

Using machine learning to model dose–response relationships [PDF]

open access: yesJournal of Evaluation In Clinical Practice, 2016
Rationale, aims and objectivesEstablishing the relationship between various doses of an exposure and a response variable is integral to many studies in health care.
Linden, Ariel   +2 more
core   +2 more sources

Model-based meta-analysis of HbA1c reduction across SGLT2 inhibitors using dose adjusted by urinary glucose excretion [PDF]

open access: yesScientific Reports
This study was aimed to evaluate whether the dose–response relationship of the sodium glucose co-transporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)—canagliflozin, dapagliflozin, empagliflozin, ipragliflozin ...
Hiromi Sato   +5 more
doaj   +2 more sources

Evaluating the relationship between Ex3 vNTR and rs3758653 polymorphisms in DRD4 genes in children with attention deficit hyperactivity disorder with respect to the dose of methylphenidate [PDF]

open access: yesمجله پزشکی دانشگاه علوم پزشکی تبریز, 2022
Background. Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders starting at an early age with symptoms of attention deficit hyperactivity disorder and impulsivity.
Shahrokh Amiri   +5 more
doaj   +1 more source

Adverse effects of long term, continual administration of high doses of albendazole in the treatment of echinococcal disease [PDF]

open access: yesVojnosanitetski Pregled, 2008
Background/Aim. Modern treatment of cystic echinococcosis, except for surgical treatment and percutaneous drainage of cyst considers also administration of albendazole as a type of individual therapy.
Jevtić Miodrag   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy